Articles tagged "Kidney transplantation"

2022 American Transplant Congress
Association Between CT Measurements of Body Composition Before Kidney Transplantation and Post-Transplantation Outcomes
Y. Liu, O. Shafaat, X. Chen, C. Weiss, D. Segev, M. McAdams-DeMarco
Johns Hopkins University, Baltimore, MD
*Purpose: Body composition has been found to be associated with the risks of post-kidney transplantation (KT) outcomes. However, it is unclear which pre-KT computed tomography…
2022 American Transplant Congress
Non-White and Low-Socioeconomic Status Patients Are Less Likely to Present for Preemptive Kidney Transplant Evaluation: An Assessment of Referrals at a Single Center Serving a Diverse Urban Population
T. Menser, M. J. Hobeika, E. Hsu, L. W. Moore, A. D. Waterman, A. O. Gaber, R. J. Knight
Houston Methodist, Houston, TX
*Purpose: While preemptive kidney transplantation is the optimal renal replacement therapy for patients with end-stage kidney disease (ESKD), low rates of preemptive transplant, particularly for…
2022 American Transplant Congress
Interleukin-31 (IL-31) and Leukemia Inhibitory Factor (LIF) Are Upregulated in Acute Rejection of Kidney Allograft
I. Striz, L. Krupickova, M. Fialova, M. Novotny, E. Cecrdlova, O. Viklicky
Institute for Clinical and Experimental Medicine, Praha, Czech Republic
*Purpose: Interleukin-31 (IL-31) and leukemia inhibitory factor (LIF) belong to the IL-6 cytokine family clustered by their pro-inflammatory properties and a shared signaling pathway of…
2022 American Transplant Congress
Factors Influencing Access to Kidney Transplantation (FIAT): An Integrative Multiphasic Stakeholders’ Perspective
R. v. Merweland¹, A. Luchtenburg¹, J. van Busschbach¹, J. van de Wetering¹, S. Ismail²
¹Medical Psychology, Erasmus MC, Rotterdam, Netherlands, ²Erasmus MC, Rotterdam, Netherlands
*Purpose: Despite that various barriers to optimal access to transplantation are described in literature,there is no research combining the perspectives of all stakeholders in renal…
2022 American Transplant Congress
Kidney Transplant Professionals’, Recipients’ and Caregivers’ Perspectives on the Use of Precision Medicine in Kidney Transplantation
F. Ballesteros Gallego¹, A. Affdal¹, M. Malo², R. Sapir-Pichhadze³, M. Fortin¹
¹CRCHUM, Montreal, QC, Canada, ²University of Montreal, Montreal, QC, Canada, ³McGill University, Montreal, QC, Canada
*Purpose: Kidney transplantation is the optimal treatment for end-stage kidney disease. However, antibody-mediated rejection can lead to graft loss. The use of Precision Medicine (PM)…
2022 American Transplant Congress
Single-cell Transcriptomic Analysis Of Peripheral Blood Reveals The Disparate Subsets Of Innate Immune Cells In Kidney Transplant Recipient With BK Virus Infection
H. BAE¹, J. Ryu², J. Jang¹, J. Lee¹, G. Ko¹, H. PARK¹, E. Oh³
¹Department of Biomedical Science, Graduate School, College of medicine, The Catholic university of Korea, Seoul, Seoul, Korea, Republic of, ²Department of Laboratory Medicine, College of Medicine, Seoul St. Mary’s hospital, the Catholic University of Korea, seoul, Korea, Republic of, ³Catholic University Department of Laboratory Medicine, Seoul 137-040, Korea, Republic of
*Purpose: BK virus (BKV) infection is a common problem in kidney transplant recipients receiving immunosuppressive therapy, resulting in a serious complications including BKV-associated nephropathy and…
2021 American Transplant Congress
Characterisation of Distinct Graft Infiltrates Following Cellular Therapy in Kidney Transplant Recipients
M. O. Brook¹, P. N. Harden², I. Roberts², W. R. Mulley³, J. Hester¹, M. E. Reinders⁴, F. Issa¹
¹Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom, ²Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom, ³Department of Nephrology, Monash Medical Centre, Melbourne, Australia, ⁴Division of Nephrology and Transplant Center, Leiden University Medical Center, Leiden, Netherlands
*Purpose: Cellular therapy is an emerging treatment in the field of clinical transplantation with the potential to improve both short and long-term transplant outcomes. We…
2021 American Transplant Congress
The Impact of 4-weeks of Supervised Exercise on Frailty and Lower Extremity (LE) Function in Patients with Advanced Chronic Kidney Disease (CKD)
E. Lorenz, L. Hickson, R. Weatherly, K. Thompson, M. Hogan, C. Kennedy
Mayo Clinic, Rochester, MN
*Purpose: Although frailty is a modifiable risk factor for morbidity and mortality among kidney transplant (KT) candidates, the optimal duration of effective prehabilitation interventions is…
2021 American Transplant Congress
Development and Validation of a Novel Peripheral Blood Based Gene Signature for Acute Rejection Following Renal Transplantation
D. Zhang, Y. Wang, X. Hu
Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
*Purpose: The aim of this study is to utilize advanced machine learning methods to construct a peripheral blood-based gene signature for acute rejection following kidney…
2021 American Transplant Congress
De-novo Use Comparison Between Extended-release Once-daily Tacrolimus (Envarsus Xr®) and Immediate-release Twice-daily Tacrolimus (Prograf®) – A Single Center’s Experience
N. Singh¹, T. Le¹, M. S. Naseer¹, S. Asmil¹, A. Palermini¹, A. Qamar¹, R. Chand¹, S. Tandukar¹, D. Aultman², H. Shokouh-Amiri², G. Zibari²
¹Transplant, John C. McDonald Regional Transplant Center - Willis Knighton Medical Center, Shreveport, LA, ²Advanced Surgery, John C. McDonald Regional Transplant Center - Willis Knighton Medical Center, Shreveport, LA
*Purpose: Envarsus XR® is approved for de-novo use post-kidney transplantation at a higher starting dose (0.14mg/kg/day) as compared with Prograf® (0.1 mg/kg/day) despite better bioavailability.…